Akihito Nagata
Komagome, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.
Journal: Science translational medicine
Published: April 15, 2026
FLT3 inhibitor and venetoclax therapy in elderly patients with relapsed/refractory FLT3-ITD+ AML: A report of three cases.
Journal: Leukemia research reports
Published: March 31, 2025
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies.
Journal: Bone marrow transplantation
Published: November 11, 2023
Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes.
Journal: Scientific reports
Published: December 20, 2022
Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.
Journal: Annals of medicine
Published: October 18, 2022
Weight-adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remission.
Journal: Leukemia & lymphoma
Published: September 06, 2022
Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: May 19, 2022
A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 10, 2022
Combination therapy with low doses of ponatinib and steroids in elderly and frail patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal: Annals of hematology
Published: January 23, 2022
Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation.
Journal: International journal of hematology
Published: August 23, 2021
Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less.
Journal: Asia-Pacific journal of clinical oncology
Published: July 30, 2021
Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI.
Journal: International journal of hematology
Published: April 28, 2021
Last Updated: 09/26/2026